Tianshiwei

Developer of transdermal drug delivery technology for ophthalmology

placeWuhan, Hubei, China calendar_todayFounded 2019 language news.pedaily.cn

Innovation

1 patent family (1 granted); filing pace dormant.

Investor mix

1 investor on record; lead investors include Co-win Ventures.

Investor typeCountShare
Venture capital1100%
Coming soon